About Andrew Barrett
Form D filings for Cessation Therapeutics in 2024 list Andrew Barrett as CEO.
Andrew Barrett first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Andrew Barrett in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Andrew Barrett works with at each company, as listed on that company's latest Form D.
Cessation Therapeutics, Inc. · Form D, Apr 3, 2024
ST
Sharon Tetlow
Director
JH
John Harkey
Director
DF
Daniel Fine
Director
JS
Jay Shepard
Director
MP
Mark Pearson
Director